Raymond James Downgrades Acceleron Pharma (XLRN) to Market Perform

October 4, 2021 6:24 AM EDT Send to a Friend
Raymond James analyst Danielle Brill downgraded Acceleron Pharma (NASDAQ: XLRN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login